Bill is the Head of Strategy at XtalPi, Inc., an AI-driven pharmaceutical technology company, where he leverages two decades of experience applying physics-based in silico solutions to critical problems in discovery and development. He is actively involved in forging strategic partnerships, raising capital and creating innovative business models. Prior to that, he was Vice President of Strategic Business at Schrodinger, LLC, a leader in predictive software modeling and drug discovery services. There he created strategic partnerships with major pharmaceutical companies that provided the basis for Schrödinger LLC’s entry and expansion strategies and also led voice of customer campaigns to inform disruptive innovation in new product development.
Bill held a postdoctoral fellowship at the University of California, Berkeley in theoretical chemistry after earning a Ph.D. from the University of South Florida in computational chemistry. He then earned an MBA in Technology Evaluation and Commercialization from North Carolina State University, where he cofounded an AI-driven company specializing in bioprocessing.